Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in FTRE — Fortrea Holdings Inc.

CIK 884546 SAN FRANCISCO, CA
Back to FTRE Full portfolio

Position in FTRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$43,315,960
+$13,099,681 QoQ
Shares Held
2,489,423
-22.4% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#11
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FTRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. FTRE ranks #41 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in FTRE

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,315,960 2,489,423
2026-03-31 $30,216,279 3,207,673
2025-12-31 $55,528,250 3,219,029
2025-09-30 $22,339,421 2,653,138
2025-06-30 $8,840,940 1,789,664
2025-03-31 $7,187,758 952,021
2024-12-31 $11,430,529 612,897
2024-09-30 $11,808,560 590,428
2024-06-30 $13,097,077 561,143
2024-03-31 $22,759,741 567,009
2023-12-31 $21,549,319 617,459
2023-09-30 $16,595,094 580,451